VIARES’ Post

𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝 𝐜𝐨𝐦𝐦𝐨𝐧 𝐦𝐢𝐬𝐜𝐨𝐧𝐜𝐞𝐩𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 https://lnkd.in/essgAApm As clinical trials are the backbone of medical progress, yet many myths and misconceptions hold people back from participating. This can hinder scientific advancement and delay access to potentially life-saving treatments. This blog post from CliniLaunch dives deep into these misconceptions, separating fact from fiction. 𝐋𝐞𝐚𝐫𝐧 𝐚𝐛𝐨𝐮𝐭:  -> How much control participants have over their care during a trial -> Why doctors prioritize participant safety and well-being -> The importance of informed consent and the freedom to withdraw at any time Empower yourself and others to make informed decisions about clinical research. Share this post and let’s work together to advance healthcare! For more info: Visit: www.clinilaunchresearch.in Contact: +91-8904269998 | contact@clinilaunchresearch.in #ClinicalTrials #MedicalResearch #Breakthroughs #PatientEmpowerment #CliniLaunch

High-quality data is the lifeblood of clinical research. Learn more about the value of metrics and their impact on the success of clinical research. https://lnkd.in/eChPKkqf #clinicalresearch #clinicaldata

Metrics are vital signposts on the road of clinical research for precision and objectivity. Learn more about the value of metrics and their impact on the success of clinical research. https://lnkd.in/eChPKkqf #clinicalresearch #metrics

Are clinical trial costs eating into your research budget? We hear you. Thankfully, there are ways to reduce trial expenses without sacrificing quality. This article provides 6 strategies to keep your trials running smoothly and your budget in-line. No compromises, just good science and smart choices. https://hubs.li/Q02rMh590 #ClinicalTrialCosts #ClinicalTrials #MedicalTrials #ClinicalResearch

Did you know there are over 498,000 clinical trials happening worldwide in 2024? 🌎 Discover how these studies are transforming healthcare and advancing medical science! #ClinicalTrials #MedicalResearch #HealthcareInnovation #CareTrials https://lnkd.in/gBGudjq6

Navigating the clinical and translational research world? Chartis can help you with the ABC's.

Joining a research study or clinical trial can involve a lot of alphabet soup for the patient given all the complexity involved.  As noted in a recent #ACRP blog post, a new initiative from The Multi-Regional Clinical Trials Center is aiming to provide a glossary of common clinical research terms for use by research professionals and patients alike: https://lnkd.in/duSeQd_8   At Chartis, we strive to work with research leaders to keep patients at the center of their care, including best practices on participant-facing communication and study design.  We’re here to strategize on best practices and how to implement in your organization.    #ClinicalTrials #HealthLiteracy #ClinicalResearch  

Today is International Clinical Trials Day!  A day to celebrate not only the scientists developing treatments but also the incredible volunteers who contribute to medical progress by testing new treatments.  However, traditional approaches often struggle to keep participants engaged, leading to high dropout rates. This can delay breakthroughs and inflate research costs.  It's time to create a more engaging and rewarding research experience for participants with spencer®, the innovative Smart Pill Dispenser that fosters a sense of partnership and empowers participants.  Read our blog post, "Engaging Participants, Boosting Clinical Trials" to learn more: https://bit.ly/3KpD0ax #InternationalClinicalTrialsDay #ClinicalTrialInnovation #ClinicalTrials

Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials https://lnkd.in/diHsfdbU It is important to design clinical trials to include all those who may benefit from the intervention being tested. Several frameworks have been developed to help researchers think about the barriers to inclusi...

#Selective #reporting and #publication #bias in medical journals have undermined the integrity of the clinical evidence system. https://lnkd.in/dY983aYr There are many insights in this excellent article but PICO is not enough. At least three indicators could help: NNT (number of patients you need to treat to prevent one additional bad outcome ), NNH (number of individuals who must be treated so that one of them presents an adverse reaction accountable to the treatment) and Fragility Index (number indicating how many patients would be required to convert a trial from being statistically significant to not significant).